Ally Bridge Group (Ny) LLC Portfolio Holdings

Ally Bridge Group (Ny) LLC

  • $76.1 Million
  • Q1 2025

Ally Bridge Group (Ny) LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $76.1 Million distributed in 28 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spring Works Therapeutics, Inc. with a value of $12.4M, Verona Pharma PLC with a value of $8.83M, Axsome Therapeutics, Inc. with a value of $8.41M, Tarsus Pharmaceuticals, Inc. with a value of $6.57M, and Blueprint Medicines Corp with a value of $6.57M.

Examining the 13F form we can see an decrease of $12M in the current position value, from $88.1M to 76.1M.

Ally Bridge Group (Ny) LLC is based out at New York, NY

Below you can find more details about Ally Bridge Group (Ny) LLC portfolio as well as his latest detailed transactions.

Portfolio value $76.1 Million
Healthcare: $75 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.92B
$12.4 Million 16.31% of portfolio
281,139
Q1 2025 Added 414.04%
$5.08B
$8.83 Million 11.61% of portfolio
139,067
Q1 2025 New
$4.71B
$8.41 Million 11.06% of portfolio
72,113
Q1 2025 Added 8.18%
$1.2B
$6.57 Million 8.64% of portfolio
127,932
Q1 2025 Reduced 26.11%
$7.64B
$6.57 Million 8.63% of portfolio
74,192
Q1 2025 Added 32.74%
$9.58B
$6.49 Million 8.54% of portfolio
85,110
Q1 2025 Reduced 25.58%
$353M
$4.32 Million 5.67% of portfolio
686,219
Q1 2025 Reduced 12.19%
$1.12B
$3.5 Million 4.59% of portfolio
243,086
Q1 2025 Reduced 0.59%
$2.57B
$3.28 Million 4.31% of portfolio
77,896
Q1 2025 Reduced 33.31%
$589M
$3.27 Million 4.3% of portfolio
2,056,637
Q1 2025 Added 91.35%
$1.96B
$2.34 Million 3.07% of portfolio
69,603
Q1 2025 Reduced 46.17%
$936M
$2.26 Million 2.97% of portfolio
102,650
Q1 2025 Added 23.41%
$1.03B
$2.19 Million 2.88% of portfolio
81,292
Q1 2025 Reduced 9.97%
$35.9M
$1.46 Million 1.91% of portfolio
817,939
Q4 2024 New
$53.2M
$1.45 Million 1.9% of portfolio
777,020
Q1 2025 Added 11.05%
$0
$1.04 Million 1.37% of portfolio
1,484,699
Q1 2025 Reduced 6.78%
$9.26M
$706,000 0.93% of portfolio
1,157,448
Q1 2025 Reduced 26.59%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 19.8%
Axsome Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 23.99%
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 24.29%
Edgewise Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 37.45%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q1 2025 Added 112.49%
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 18.13%
Korro Bio Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 15.5%

Summary

  • Portfolio
  • No. of Stocks 28
  • Current Value $76.1 Million
  • Prior Value $88.1 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 4 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email